コンテンツへスキップ
Merck
  • Effects of oral hyposensitization therapy with nickel on haemoglobin and haematocrit values in sensitized patients.

Effects of oral hyposensitization therapy with nickel on haemoglobin and haematocrit values in sensitized patients.

International journal of immunopathology and pharmacology (2012-06-16)
A Tammaro, A Narcisi, P P Di Russo, C Abruzzese, C Caperchi, F Persechino, F R Parisella, S Persechino
要旨

Nickel deficiency leads to reduced iron content in organs and to reduced hemoglobin levels and haematocrit counts. We carried out a clinical trial of oral hyposensitization therapy with low doses of nickel on a group of 20 patients affected by systemic allergy to this sensitizer element and with a chronic relapsing low hemoglobin level and haematocrit count. We obtained interesting results on maintaining these values in treated patients.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
硫酸ニッケル(II) 六水和物, ACS reagent, ≥98%
Sigma-Aldrich
硫酸ニッケル(II) 六水和物, ReagentPlus®, powder or crystals
Sigma-Aldrich
硫酸ニッケル(II) 七水和物, purum p.a., crystallized, ≥99.0% (KT)
Sigma-Aldrich
硫酸ニッケル(II), 99.99% trace metals basis
Supelco
硫酸ニッケル(II) 六水和物, ≥99.99% trace metals basis
Sigma-Aldrich
硫酸ニッケル(II) 七水和物, 99.999% trace metals basis
Sigma-Aldrich
Nickel(II) sulfate hexa-/ heptahydrate, DIN 50970 H, ≥20.6% Ni and Co basis
Sigma-Aldrich
硫酸ニッケル(II) 六水和物, SAJ first grade, 98.5-102.0%